CLINICAL_TRIALS
trial_result
· 2025-07-11
Clinical Trial Update: Lerapolturev in Recurrent Malignant Glioma [Phase 2]
Summary
Phase 2 clinical trial results update for Lerapolturev in recurrent malignant glioma; the study has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Istari Oncology, Inc. | Conditions: Malignant Glioma | Phase 2 | Status: COMPLETED | Results posted: 2025-07-11